Artelo Biosciences, Inc.
ARTLNASDAQHealthcare● Active
$1.33
+$0.00(+0.75%)
Market Cap$3103836
P/E Ratio—
52W High$85.8
52W Low$1.19
Artelo Biosciences, Inc.（ARTL）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ARTL · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-08 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.00B | $0.00B | $0.01B | $0.02B | $0.01B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.00B | $0.00B | $0.01B | $0.02B | $0.01B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.00B | $0.00B | $0.01B | $0.02B | $0.01B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.06B) | ($0.05B) | ($0.04B) | ($0.03B) | ($0.02B) |
| Total Stockholders Equity | ($0.00B) | $0.00B | $0.01B | $0.02B | $0.01B |
| Total Liab & Equity(computed) | $0.00B | $0.00B | $0.01B | $0.02B | $0.01B |
| Debt Summary | |||||
| Total Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Debt | $0.00B | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Artelo Biosciences, Inc.
关于Artelo Biosciences, Inc.（ARTL）资产负债表
Artelo Biosciences, Inc.总资产$0.00B，现金及短期投资$0.00B，总负债$0.00B，总债务$0.00B，股东权益($0.00B)。
常见问题
ARTL · 4 问Artelo Biosciences, Inc.总债务$0.00B，净债务$0.00B。
ARTL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10